Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

7.16
+1.0216.61%
Post-market: 7.03-0.1298-1.81%19:56 EDT
Volume:2.13M
Turnover:14.92M
Market Cap:370.09M
PE:-10.37
High:7.49
Open:6.98
Low:6.57
Close:6.14
52wk High:7.49
52wk Low:3.19
Shares:51.69M
Float Shares:32.94M
Volume Ratio:4.94
T/O Rate:6.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6903
EPS(LYR):-0.6050
ROE:-73.41%
ROA:-44.55%
PB:13.62
PE(LYR):-11.84

Loading ...

Craig-Hallum Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC)

TIPRANKS
·
Sep 05

DiaMedica Therapeutics Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Sep 05

Jan Stahlberg, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Sep 05

DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

DiaMedica Therapeutics Inc - May Sell Common Shares up to $100 Mln - SEC Filing

THOMSON REUTERS
·
Aug 13

DiaMedica Therapeutics Signs $100 Million Sales Agreement with TD Cowen for At-the-Market Offering

Reuters
·
Aug 13

DiaMedica Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

DiaMedica Therapeutics Q2 Pretax Profit USD -7.693 Million

THOMSON REUTERS
·
Aug 13

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Aug 09

DiaMedica Therapeutics Appoints Julie Krop, Md, as Chief Medical Officer

THOMSON REUTERS
·
Aug 06

BRIEF-Diamedica Therapeutics To Report Second Quarter 2025 Financial Results And Provide A Business Update August 13, 2025

Reuters
·
Aug 06

DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025

THOMSON REUTERS
·
Aug 06

DiaMedica Therapeutics Inc Files for Resale of up to 8.6 Mln Common Shares by the Selling Shareholders - SEC Filing

THOMSON REUTERS
·
Aug 01

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Aug 01

Jan Stahlberg, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26

Thomas Von Koch, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26